Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis

Daniela Galimberti, Diego Scalabrini, Chiara Fenoglio, Milena De Riz, Cristoforo Comi, Eliana Venturelli, Francesca Cortini, Mirko Piola, Maurizio Leone, Umberto Dianzani, Sandra D'Alfonso, Francesco Monaco, Nereo Bresolin, Elio Scarpini

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Macrophage-derived chemokine (MDC/CCL22) plays a role in Experimental Autoimmune Encephalomyelitis (EAE), the animal model of Multiple Sclerosis (MS). MDC/CCL22 gene is part of a chemokine cluster, which includes also thymus and Activation-Regulated Chemokine (TARC/CCL17). The frequency of the C/T and C/A Single Nucleotide Polymorphisms (SNPs) in the promoter and coding sequence of CCL22 as well as the C/T SNP in the promoter of CCL17 were determined in 370 patients with Multiple Sclerosis (MS) compared with 380 controls. A trend towards a decreased allelic frequency of the A allele of the CCL22 C/A SNP as well as of the T allele of the CCL17 C/T SNP was found in patients compared with controls. The frequency of the AT haplotype was significantly decreased in MS patients (P = 0.017, OR: 0.49, CI: 0.28-0.87). Stratifying patients according to gender, the observed association was even more pronounced in male patients compared with male controls (P = 0.004, OR = 0.18, 95% CI: 0.06-0.50), whereas no significant differences were observed in females. Therefore, the presence of the AT haplotype in chromosome 16 chemokine cluster is likely to confer a decreased risk of developing MS, particularly in males.

Original languageEnglish
Pages (from-to)86-90
Number of pages5
JournalJournal of the Neurological Sciences
Volume267
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2008

Fingerprint

Chromosomes, Human, Pair 16
Multigene Family
Chemokines
Multiple Sclerosis
Single Nucleotide Polymorphism
Chemokine CCL22
Chemokine CCL17
Haplotypes
Autoimmune Experimental Encephalomyelitis
Gene Frequency
Animal Models
Alleles
Genes

Keywords

  • Chemokines
  • Haplotype
  • MDC-CCL22
  • Multiple Sclerosis (MS)
  • Single Nucleotide Polymorphism (SNP)

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis. / Galimberti, Daniela; Scalabrini, Diego; Fenoglio, Chiara; De Riz, Milena; Comi, Cristoforo; Venturelli, Eliana; Cortini, Francesca; Piola, Mirko; Leone, Maurizio; Dianzani, Umberto; D'Alfonso, Sandra; Monaco, Francesco; Bresolin, Nereo; Scarpini, Elio.

In: Journal of the Neurological Sciences, Vol. 267, No. 1-2, 15.04.2008, p. 86-90.

Research output: Contribution to journalArticle

Galimberti, Daniela ; Scalabrini, Diego ; Fenoglio, Chiara ; De Riz, Milena ; Comi, Cristoforo ; Venturelli, Eliana ; Cortini, Francesca ; Piola, Mirko ; Leone, Maurizio ; Dianzani, Umberto ; D'Alfonso, Sandra ; Monaco, Francesco ; Bresolin, Nereo ; Scarpini, Elio. / Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis. In: Journal of the Neurological Sciences. 2008 ; Vol. 267, No. 1-2. pp. 86-90.
@article{e6ef54356b4b4324a6d4d0d6ef65d0b4,
title = "Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis",
abstract = "Macrophage-derived chemokine (MDC/CCL22) plays a role in Experimental Autoimmune Encephalomyelitis (EAE), the animal model of Multiple Sclerosis (MS). MDC/CCL22 gene is part of a chemokine cluster, which includes also thymus and Activation-Regulated Chemokine (TARC/CCL17). The frequency of the C/T and C/A Single Nucleotide Polymorphisms (SNPs) in the promoter and coding sequence of CCL22 as well as the C/T SNP in the promoter of CCL17 were determined in 370 patients with Multiple Sclerosis (MS) compared with 380 controls. A trend towards a decreased allelic frequency of the A allele of the CCL22 C/A SNP as well as of the T allele of the CCL17 C/T SNP was found in patients compared with controls. The frequency of the AT haplotype was significantly decreased in MS patients (P = 0.017, OR: 0.49, CI: 0.28-0.87). Stratifying patients according to gender, the observed association was even more pronounced in male patients compared with male controls (P = 0.004, OR = 0.18, 95{\%} CI: 0.06-0.50), whereas no significant differences were observed in females. Therefore, the presence of the AT haplotype in chromosome 16 chemokine cluster is likely to confer a decreased risk of developing MS, particularly in males.",
keywords = "Chemokines, Haplotype, MDC-CCL22, Multiple Sclerosis (MS), Single Nucleotide Polymorphism (SNP)",
author = "Daniela Galimberti and Diego Scalabrini and Chiara Fenoglio and {De Riz}, Milena and Cristoforo Comi and Eliana Venturelli and Francesca Cortini and Mirko Piola and Maurizio Leone and Umberto Dianzani and Sandra D'Alfonso and Francesco Monaco and Nereo Bresolin and Elio Scarpini",
year = "2008",
month = "4",
day = "15",
doi = "10.1016/j.jns.2007.10.001",
language = "English",
volume = "267",
pages = "86--90",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis

AU - Galimberti, Daniela

AU - Scalabrini, Diego

AU - Fenoglio, Chiara

AU - De Riz, Milena

AU - Comi, Cristoforo

AU - Venturelli, Eliana

AU - Cortini, Francesca

AU - Piola, Mirko

AU - Leone, Maurizio

AU - Dianzani, Umberto

AU - D'Alfonso, Sandra

AU - Monaco, Francesco

AU - Bresolin, Nereo

AU - Scarpini, Elio

PY - 2008/4/15

Y1 - 2008/4/15

N2 - Macrophage-derived chemokine (MDC/CCL22) plays a role in Experimental Autoimmune Encephalomyelitis (EAE), the animal model of Multiple Sclerosis (MS). MDC/CCL22 gene is part of a chemokine cluster, which includes also thymus and Activation-Regulated Chemokine (TARC/CCL17). The frequency of the C/T and C/A Single Nucleotide Polymorphisms (SNPs) in the promoter and coding sequence of CCL22 as well as the C/T SNP in the promoter of CCL17 were determined in 370 patients with Multiple Sclerosis (MS) compared with 380 controls. A trend towards a decreased allelic frequency of the A allele of the CCL22 C/A SNP as well as of the T allele of the CCL17 C/T SNP was found in patients compared with controls. The frequency of the AT haplotype was significantly decreased in MS patients (P = 0.017, OR: 0.49, CI: 0.28-0.87). Stratifying patients according to gender, the observed association was even more pronounced in male patients compared with male controls (P = 0.004, OR = 0.18, 95% CI: 0.06-0.50), whereas no significant differences were observed in females. Therefore, the presence of the AT haplotype in chromosome 16 chemokine cluster is likely to confer a decreased risk of developing MS, particularly in males.

AB - Macrophage-derived chemokine (MDC/CCL22) plays a role in Experimental Autoimmune Encephalomyelitis (EAE), the animal model of Multiple Sclerosis (MS). MDC/CCL22 gene is part of a chemokine cluster, which includes also thymus and Activation-Regulated Chemokine (TARC/CCL17). The frequency of the C/T and C/A Single Nucleotide Polymorphisms (SNPs) in the promoter and coding sequence of CCL22 as well as the C/T SNP in the promoter of CCL17 were determined in 370 patients with Multiple Sclerosis (MS) compared with 380 controls. A trend towards a decreased allelic frequency of the A allele of the CCL22 C/A SNP as well as of the T allele of the CCL17 C/T SNP was found in patients compared with controls. The frequency of the AT haplotype was significantly decreased in MS patients (P = 0.017, OR: 0.49, CI: 0.28-0.87). Stratifying patients according to gender, the observed association was even more pronounced in male patients compared with male controls (P = 0.004, OR = 0.18, 95% CI: 0.06-0.50), whereas no significant differences were observed in females. Therefore, the presence of the AT haplotype in chromosome 16 chemokine cluster is likely to confer a decreased risk of developing MS, particularly in males.

KW - Chemokines

KW - Haplotype

KW - MDC-CCL22

KW - Multiple Sclerosis (MS)

KW - Single Nucleotide Polymorphism (SNP)

UR - http://www.scopus.com/inward/record.url?scp=39049156297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049156297&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.10.001

DO - 10.1016/j.jns.2007.10.001

M3 - Article

VL - 267

SP - 86

EP - 90

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -